Karus Therapeutics presenting at NCRI Cancer Conference

Stephen Shuttleworth, CSO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting two posters at the 10th NCRI Cancer Conference, 2-5 November 2014 in Liverpool. For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.

Karus Therapeutics presenting at SACHS Biotech in Europe Forum

Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that Simon Kerry, CEO, will be presenting at the SACHS Biotech in Europe Forum, 30 September – 01 October, 2014 in Basel, Switzerland. The company presentation will take place at 15:45 CET on 30th September […]